IRF4公司
免疫系统
生发中心
肿瘤微环境
癌症研究
滤泡性淋巴瘤
生物
淋巴瘤
免疫学
干扰素调节因子
B细胞
转录因子
先天免疫系统
基因
抗体
遗传学
作者
Surendra Dasari,Kerstin Wenzl,Geoffrey M. Nelson,Emmanuel Contreras Guzman,Zhiquan Wang,Loïc Chartier,Zhi-Zhang Yang,José C. Villasboas,Joshua Olson,Prithviraj Mukherjee,Vaishali Bhardwaj,Xinyi Tang,Brianna J. Negaard,Johannes L. Zakrzewski,Rebecca L. King,Sarah Huet,Bruno Tesson,Matthew J. Maurer,Franck Morschhauser,Grzegorz S. Nowakowski
标识
DOI:10.1158/2643-3230.bcd-24-0223
摘要
We show that IRF4 controls immune and metabolic signaling with functional effects on the cross-talk between B and T cells, resulting in a suppressive immune microenvironment when IRF4 is overexpressed in lymphoma. This underscores the importance of IRF4 as a pivotal therapeutic target to restore antitumor immunosurveillance for IRF4-associated lymphomas.
科研通智能强力驱动
Strongly Powered by AbleSci AI